Ifom-Istituto Fondazione di Oncologia Molecolare Ets

Ifom-Istituto Fondazione di Oncologia Molecolare Ets is a research organisation in Milano, Italy that has taken part in 52 EU-funded projects since 2008, receiving €34.2M in EU funding and leading 24 as coordinator.

EU funding received€34.2M
EU projects52
As coordinator24
Running now9
First EU project2008
Latest project2025
CountryItaly
EU registration (PIC)999534367
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Ifom-Istituto Fondazione di Oncologia Molecolare Ets's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€18.5M · 22 projects
  • Horizon 2020€10.5M · 21 projects
  • Horizon Europe€4.9M · 8 projects
  • Digital Europe Programme (DIGITAL)€225k · 1 project

Projects

52 EU-funded projects, newest first. Ifom-Istituto Fondazione di Oncologia Molecolare Ets led 24 of them as coordinator. Each links to the official record.

  • EpiMetaPDOCoordinator

    Dissecting mechanisms of epigenetic reprogramming driving metastatic transition using cancer patient-derived organoids

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €173ktheir share
  • TOPOMECHAssociated partner

    Genome topology and mechanical stress

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • METABALANCANCERPartner

    Setting the optimal balance between metabolite supplementation and deprivation in cancer therapy

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €744ktheir share
  • FolLyway2HITCoordinator

    Deciphering the role of immunoglobulin classes in shaping Follicular Lymphoma molecular heterogeneity and evolution

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €173ktheir share
  • TELOVACCINECoordinator

    Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €150ktheir share
  • SagittariusCoordinator

    A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €3.4Mtheir share
  • SHAPINCELLFATEAssociated partner

    Impact of cell shapes on cell behaviour and fate

    Horizon Europe · 2023–2029 · Project on CORDIS ↗

  • CohesiNetPartner

    Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €259ktheir share
  • EUCAIMPartner

    European Federation for Cancer Images

    Digital Europe Programme (DIGITAL) · 2023–2026 · Project on the EU portal ↗

    €225ktheir share
  • TARGETPartner

    Targeting DNA repair pathways, sparking anti cancer immunity

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €715ktheir share
  • PERSIST-SEQPartner

    Building a reproducible single-cell experimental workflow to capture tumour cell persistence

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €367ktheir share
  • METAREPAIRCoordinator

    INVESTIGATING THE IMPACT OF NUTRITIONAL METABOLISM ON DNA DAMAGE REPAIR IN CANCER

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €171ktheir share
  • OrganVisionPartner

    OrganVision: Technology for real-time visualizing and modelling of fundamental process in living organoids towards new insights into organ-specific health, disease, and recovery

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • FIREQUENCHERCoordinator

    Pharmacological inhibition of macrophage activation

    Horizon 2020 · 2021–2022 · Project on CORDIS ↗

    €150ktheir share
  • BCRlossToBWinnerCoordinator

    Genetic determinants promoting resistance to BCR-loss in B-cell lymphomas

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €71ktheir share
  • TeloRNAgingCoordinator

    The role of damage-induced non coding RNA in the control of DNA damage response activation at telomeres in aging

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €2.5Mtheir share
  • aDDRessPartner

    Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €262ktheir share
  • MechanoSpectrinCoordinator

    Dynamic and Mechanical Role of Spectrin in Membrane-Cytoskeleton Interplay

    Horizon 2020 · 2018–2020 · Project on CORDIS ↗

    €168ktheir share
  • COSMICPartner

    COmbatting disorders of adaptive immunity with Systems MedICine

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €258ktheir share
  • V-EPCCoordinator

    Inherited disfunctions of brain microcirculation

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €2.5Mtheir share
  • SPLICANCERCoordinator

    Regulation and reprogramming of alternative splicing in cellular transformation

    Horizon 2020 · 2017–2019 · Project on CORDIS ↗

    €168ktheir share
  • RNAgingCoordinator

    The role of non coding RNA in organismal ageing

    Horizon 2020 · 2017–2018 · Project on CORDIS ↗

    €150ktheir share
  • SYNTRAINPartner

    Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €258ktheir share
  • REPSUMODDTCoordinator

    Mechanisms and regulators coordinating replication integrity and DNA damage tolerance.

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €2.0Mtheir share
  • MECHANOCHECKCoordinator

    ATR-mediated mechanotransduction and connections with the actin cytoskeleton

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €180ktheir share
  • ENVERESPCoordinator

    Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €168ktheir share
  • QUANTEXBIOPartner

    Quantitative and Experimental Biology

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

  • BtRAINPartner

    Brain barriers training

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €258ktheir share
  • DDRNACoordinator

    DDRNA-based cancer therapy targeted telomeres

    Horizon 2020 · 2015–2016 · Project on CORDIS ↗

    €149ktheir share
  • NANOFACTURINGPartner

    The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €77ktheir share
  • DNAMEREPPartner

    The role of essential DNA metabolism genes in vertebrate chromosome replication

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €1.9Mtheir share
  • 7TReImHoPartner

    7kDa TSLP as a novel type of anti-inflammatory agent to re-establish immune homeostasis

    FP7 (2007 to 2013) · 2013–2014 · Project on CORDIS ↗

    €19ktheir share
  • DDRNACoordinator

    A novel direct role of non coding RNA in DNA damage response activation

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €2.3Mtheir share
  • COSMOPHOS-NANOPartner

    Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €313ktheir share
  • VesselPartner

    Vascular Endothelial interactionS and SpEciaLization

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €484ktheir share
  • CodeAgePartner

    The role of Chronic DNA damage in Ageing and Age-related pathology

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €241ktheir share
  • ADDRESSPartner

    Joint training and research network on Chromatin Dynamics and the DNA Damage Response

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €492ktheir share
  • REPTRACoordinator

    Mechanisms coordinating chromosome replication with transcription

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €189ktheir share
  • THE METAENDOMATRIXCoordinator

    THE ENDOCYTIC AND CYTOSKELETAL MATRIX IN THE PLASTICITY OF TUMOR CELL INVASION AND MIGRATION

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €2.2Mtheir share
  • WNT FOR BRAINCoordinator

    Transcriptional regulation of endothelial blood brain barrier differentiation by Wnt signaling

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €2.4Mtheir share
Show 12 more projects
  • AID RecruitmentCoordinator

    Targeting of DNA deaminase AID via transcription and the RNA pol II elongation complex

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

    €180ktheir share
  • ENDOSTEMPartner

    Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €464ktheir share
  • JUSTBRAINPartner

    Blood-brain barrier junctions as targets for paracellular drug delivery to the brain

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €618ktheir share
  • REPSUBREPCoordinator

    Regulatory mechanisms coordinating replication integrity and intra-S repair

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €1.8Mtheir share
  • SIPODPartner

    A Coordinated and Structured International Post-Doctoral Program to Foster Trans-national Mobility and Independent Career of Scientists in Biomedicine

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

  • MAMMASTEMCoordinator

    Molecular mechanisms of the regulation of mammary stem cell homeostasis and their subversion in cancer

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €2.3Mtheir share
  • OPTISTEMPartner

    Optimization of stem cell therapy for clinical trials of degenerative skin and muscle diseases

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €411ktheir share
  • ANGIOSCAFFPartner

    Angiogenesis-inducing Bioactive and Bioresponsive Scaffolds in Tissue Enginering

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €272ktheir share
  • EUSTROKEPartner

    European Stroke Research Network

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €675ktheir share
  • GENICAPartner

    Genomic Instability in Cancer and Precancer

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €275ktheir share
  • PREPOBEDIACoordinator

    NOVEL PREP1-DEPENDENT TRANSCRIPTIONAL NETWORKS IN THE CONTROL OF INSULIN SENSITIVITY

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €637ktheir share
  • GENINCAPartner

    Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €277ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • allergology
  • alzheimer
  • arteriosclerosis
  • asthma
  • biomaterials
  • breast cancer
  • carbohydrates
  • cell biology
  • cerebrovascular diseases
  • chromosomes
  • civil society
  • colorectal cancer

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime